Marshall Wace
SRGA

Marshall Wace’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Marshall Wace’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-798
Closed -$66K – 2213
2019
Q4 		$66K Sell
798
-732
-48% -$51.3K ﹤0.01% 1516
2019
Q3 		$131K Sell
1,530
-2,720
-64% -$290K ﹤0.01% 1355
2019
Q2 		$542K Sell
4,250
-4,719
-53% -$680K ﹤0.01% 1065
2019
Q1 		$1.62M Buy
8,969
+224
+3% +$32.4K 0.02% 808
2018
Q4 		$971K Buy
8,745
+6,543
+297% +$852K 0.01% 921
2018
Q3 		$297K Buy
+2,202
New +$304K ﹤0.01% 1013

Other funds holding SRGA

PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
KFO
Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Marshall Wace's SRGA Position: Q1 2020 in Review

Marshall Wace sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q1 2020, closing a stake of 798 shares — an estimated $66K sold.

Marshall Wace first reported a position in SRGA in Q3 2018 and held it in 6 quarters. The position peaked at $1.62M in Q1 2019. 83 funds tracked by Wall St. Rank hold SRGA as of Q1 2020.

  • Marshall Wace reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Marshall Wace sold 798 Surgalign Holdings, Inc. Common Stock shares in Q1 2020, an estimated $66K.
  • Marshall Wace first reported a position in Surgalign Holdings, Inc. Common Stock in Q3 2018 and held it in 6 quarters.
  • Marshall Wace's Surgalign Holdings, Inc. Common Stock position peaked at $1.62M in Q1 2019.
  • 83 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q1 2020.

Based on Marshall Wace's 13F filing for Q1 2020, filed 15 May 2020.